Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review

Authors

Daniel Bishev, HCA HealthcareFollow
Stephanie Fabara, HCA HealthcareFollow
Isaac Loseke, HCA HealthcareFollow
Akankcha Alok, HCA HealthcareFollow
Hashim Al-Ani, HCA HealthcareFollow
Yvette Bazikian, HCA HealthcareFollow

Files

Division

North Florida

Hospital

North Florida Regional Medical Center

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2023

Keywords

mavacamten, hypertrophic cardiomyopathy

Disciplines

Cardiovascular Diseases | Internal Medicine | Medicine and Health Sciences

Original Publisher

FMA Conference

Recommended Citation

Bishev, Daniel; Fabara, Stephanie; Loseke, Isaac; Alok, Akankcha; Al-Ani, Hashim; and Bazikian, Yvette, "Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review" (2023). North Florida Division GME Research Day 2023. 8.
https://scholarlycommons.hcahealthcare.com/northflorida2023/8